Nicolas Duployez
- Hematology top 2%
- Acute Myeloid Leukemia Research 52
- Chronic Myeloid Leukemia Treatments 11
- Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 19
-
- Cancer Genomics and Diagnostics 15
- Rheumatology top 10%
-
- Acute Lymphoblastic Leukemia research 15
-
- Protein Degradation and Inhibitors 8
- Histone Deacetylase Inhibitors Research 6
-
- Immunodeficiency and Autoimmune Disorders 4
- Co-authors
- Claude PreudhommeNicolas BoisselAlice Marceau‐RenautHervé DombretAline RennevilleÉric JourdanMartin FigeacOmar Abdel‐Wahab
- Cited by
- HematologyGeneticsCancer Research
- Partner nations
- FranceUnited StatesNetherlands
In The Last Decade
Nicolas Duployez
58 papers receiving 944 citations
Peers
Comparison fields: 5 of 52
- Hematology 621
- Genetics 303
- Cancer Research 135
- Rheumatology 135
- Public Health, Environmental and Occupational Health 190
Countries citing papers authored by Nicolas Duployez
This map shows the geographic impact of Nicolas Duployez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Duployez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Duployez more than expected).
Fields of papers citing papers by Nicolas Duployez
This network shows the impact of papers produced by Nicolas Duployez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Duployez. The network helps show where Nicolas Duployez may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nicolas Duployez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 8 | |
| 6 | 2023 | 3 | |
| 7 | 2022 | 4 | |
| 8 | 2022 | 0 | |
| 9 | 2022 | 2 | |
| 10 | 2021 | 0 | |
| 11 | 2021 | 10 | |
| 12 | 2021 | 99 | |
| 13 | 2020 | 36 | |
| 14 | 2020 | 8 | |
| 15 | 2020 | 38 | |
| 16 | 2020 | 6 | |
| 17 | 2018 | 8 | |
| 18 | 2017 | 46 | |
| 19 | 2016 | 6 | |
| 20 | 2016 | 14 |
About Nicolas Duployez
Nicolas Duployez is a scholar working on Hematology, Genetics, Cancer Research, Public Health, Environmental and Occupational Health and Rheumatology, having authored 67 papers that have together received 950 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (52 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (19 papers), Acute Lymphoblastic Leukemia research (15 papers), Cancer Genomics and Diagnostics (15 papers), Chronic Myeloid Leukemia Treatments (11 papers), Protein Degradation and Inhibitors (8 papers), Histone Deacetylase Inhibitors Research (6 papers) and Immunodeficiency and Autoimmune Disorders (4 papers). The work is most often cited by research in Hematology (621 citations), Genetics (303 citations), Cancer Research (135 citations), Rheumatology (135 citations) and Public Health, Environmental and Occupational Health (190 citations). Nicolas Duployez has collaborated with scholars based in France, United States and Netherlands. Frequent co-authors include Claude Preudhomme, Nicolas Boissel, Alice Marceau‐Renaut, Hervé Dombret, Aline Renneville, Éric Jourdan, Martin Figeac, Omar Abdel‐Wahab, Hélène Lapillonne and Arnaud Petit. Their work appears in journals such as Blood, British Journal of Haematology, Blood Advances, HemaSphere and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.